Absci Corp. (ABSI)
8.82
+0.02
(+0.23%)
USD |
NASDAQ |
Sep 04, 16:00
8.81
-0.01
(-0.11%)
After-Hours: 20:00
Absci Research and Development Expense (Quarterly) : 22.62M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.62M |
| March 31, 2026 | 19.28M |
| December 31, 2025 | 25.35M |
| September 30, 2025 | 19.25M |
| June 30, 2025 | 20.46M |
| March 31, 2025 | 16.36M |
| December 31, 2024 | 18.38M |
| September 30, 2024 | 17.98M |
| June 30, 2024 | 15.26M |
| March 31, 2024 | 12.24M |
| December 31, 2023 | 11.77M |
| September 30, 2023 | 11.03M |
| June 30, 2023 | 12.11M |
| Date | Value |
|---|---|
| March 31, 2023 | 12.66M |
| December 31, 2022 | 11.32M |
| September 30, 2022 | 15.52M |
| June 30, 2022 | 16.24M |
| March 31, 2022 | 15.83M |
| December 31, 2021 | 15.77M |
| September 30, 2021 | 10.73M |
| June 30, 2021 | 11.04M |
| March 31, 2021 | 7.05M |
| December 31, 2020 | 4.597M |
| September 30, 2020 | 2.692M |
| June 30, 2020 | 2.252M |
| March 31, 2020 | 1.907M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Twist Bioscience Corp. | 18.02M |
| Prime Medicine, Inc. | 33.40M |
| Beam Therapeutics, Inc. | 95.10M |
| Tenax Therapeutics, Inc. | 12.85M |
| Exicure, Inc. | 0.174M |